Competence And Fairness At One Of Europe’s Dynamic API Producers

Generate a summary of this article
Listen to this article
Beta
  

Don’t miss an inside look at how CF Pharma and its subsidiary, Pátriapharma, have successfully leveraged innovation and a focus on competence and fairness to be a leading CMO and generic API producer. Discover how CF Pharma has come to stand for “competent and fair” in the company’s approach to its business practices, products, and people.

Competence And Fairness At One Of Europe’s Dynamic API Producers | pdf

Don’t miss your free article from Pharma Ignite, presented in partnership with CF Pharma.

Read this article and learn how CF Pharma:

  • Is effectively addressing API supply chain issues
  • Embraces innovative solutions as part of their environmental, social, and governance (ESG) philosophy
  • Emphasizes safety and sustainability as part of their processes
  • Maintains a focus on a culture of quality
  • Innovates within their R&D teams
  • Has recently moved into providing intermediates
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Archive

Optimizing Drug Pipelines With Biophysical Methods

Optimizing Drug Pipelines With Biophysical Methods”, your view into how using biophysical techniques can enhance and streamline processes throughout the drug discovery and validation cycle.

Galapagos Expands Point-Of-Care CAR-T Study To The US

 
• By Andrew McConaghie

CEO Paul Stoffels said gaining US clearance for an IND for its novel CAR-T product was demanding, but now opens up a pathway towards a pivotal study starting in 2025.

Analysts Split On Eisai’s Chances Of Changing EU Regulator’s Mind On Leqembi

 
• By Andrew McConaghie

A final rejection of Leqembi could also spell the same fate for Lilly’s rival drug but public outcry and demand for Alzheimer’s therapies might force the regulator’s hand

GSK Looks To Catch Up In mRNA Vaccines With New CureVac Deal

 
• By Andrew McConaghie

GSK will assume full control of mRNA shots in infectious disease, allowing CureVac to cut costs and pivot its research to oncology.

More from Scrip

Sponsored by :

Clinical Trial Complexity Is Reshaping Evidence Collection Clinical trial innovation has historical - Clone

As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.

Sponsored by :

Clinical Trial Complexity Is Reshaping Evidence Collection Clinical trial innovation has historical

As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.

Primal Pictures

GB-Business-Free: ‘Content’ article that includes different Composer content published on 4 Dec after the BIOME redeployment...

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.